Role and Mechanism of PKC-δ for Cardiovascular Disease: Current Status and Perspective

被引：20
作者：
Miao, Li-na [1 ,2 ]
Pan, Deng [1 ,2 ]
Shi, Junhe [1 ]
Du, Jian-peng [1 ,3 ]
Chen, Peng-fei [1 ]
Gao, Jie [1 ,3 ]
Yu, Yanqiao [1 ,2 ]
Shi, Da-Zhuo [1 ,3 ]
Guo, Ming [1 ,3 ]
机构：
[1] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
[2] Beijing Univ Chinese Med, Dept Grad Sch, Beijing, Peoples R China
[3] China Acad Chinese Med Sci, China Heart Inst Chinese Med, Beijing, Peoples R China
来源：
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷
基金：
中国国家自然科学基金;
关键词：
cardiovascular disease; PKC-delta; kinase; mechanism; PKC; PROTEIN-KINASE-C; VASCULAR SMOOTH-MUSCLE; TISSUE GROWTH-FACTOR; PERCUTANEOUS CORONARY INTERVENTION; CA2+-ACTIVATED K+ CHANNELS; FOCAL ADHESION KINASE; ANGIOTENSIN-II; TYROSINE PHOSPHORYLATION; MYOCARDIAL-INFARCTION; ACTIVATION MECHANISMS;
D O I：
10.3389/fcvm.2022.816369
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Protein kinase C (PKC) is a protein kinase with important cellular functions. PKC-delta, a member of the novel PKC subfamily, has been well-documented over the years. Activation of PKC-delta plays an important regulatory role in myocardial ischemia/reperfusion (IRI) injury and myocardial fibrosis, and its activity and expression levels can regulate pathological cardiovascular diseases such as atherosclerosis, hypertension, cardiac hypertrophy, and heart failure. This article aims to review the structure and function of PKC-delta, summarize the current research regarding its activation mechanism and its role in cardiovascular disease, and provide novel insight into further research on the role of PKC-delta in cardiovascular diseases.
引用
收藏
页数：16
相关论文
共 50 条
  • [21] The role of PKC-θ in CD4+T cells and HIV infection: to the nucleus and back again
    Phetsouphanh, Chansavath
    Kelleher, Anthony D.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [22] Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease
    Bene, Nicholas C.
    Alcaide, Pilar
    Wortis, Henry H.
    Jaffe, Iris Z.
    STEROIDS, 2014, 91 : 38 - 45
  • [23] The Intriguing Role of TLR Accessory Molecules in Cardiovascular Health and Disease
    Bezhaeva, Taisiya
    Karper, Jacco
    Quax, Paul H. A.
    de Vries, Margreet R.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [24] Current Status of Cardiovascular Disease-Related Smartphone Apps Downloadable in China
    Xiao, Qian
    Lu, Sai
    Wang, Yanling
    Sun, Liu
    Wu, Ying
    TELEMEDICINE AND E-HEALTH, 2017, 23 (03) : 219 - 225
  • [25] Three-Dimensional Bioprinting in Cardiovascular Disease: Current Status and Future Directions
    Sun, Zhonghua
    Zhao, Jack
    Leung, Emily
    Flandes-Iparraguirre, Maria
    Vernon, Michael
    Silberstein, Jenna
    De-Juan-Pardo, Elena M.
    Jansen, Shirley
    BIOMOLECULES, 2023, 13 (08)
  • [26] Uric Acid and Cardiovascular Disease: An Update From Molecular Mechanism to Clinical Perspective
    Yu, Wei
    Cheng, Ji-Dong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [27] Untangling the Cooperative Role of Nuclear Receptors in Cardiovascular Physiology and Disease
    Paredes, Ana
    Santos-Clemente, Rocio
    Ricote, Mercedes
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [28] The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: The reasonable role of PKC-δ
    Rohilla, Ankur
    Balakumar, Pitchai
    BIOMEDICINE & PHARMACOTHERAPY, 2009, 63 (10) : 787 - 791
  • [29] Depression and cardiovascular disease in elderly: Current understanding
    Zhang, Yaxin
    Chen, Yujing
    Ma, Lina
    JOURNAL OF CLINICAL NEUROSCIENCE, 2018, 47 : 1 - 5
  • [30] Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions
    Misra, Anoop
    Tandon, Nikhil
    Ebrahim, Shah
    Sattar, Naveed
    Alam, Dewan
    Shrivastava, Usha
    Narayan, K. M. Venkat
    Jafar, Tazeen H.
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
12345